Levamisole: EMA Orders Withdrawal of Medicines Due to Rare but Serious Risk of Brain Damage

to the EMA, levamisole-associated leukoencephalopathy is:

  • Rare
  • Potentially serious
  • Possible even after a single dose of the medicine

Symptoms may appear within one day of taking the medicine or may develop several months after treatment.

What Was Levamisole Used For?

see continuation on next page

What Was Levamisole Used For?

Levamisole was mainly used to treat mild infections caused by parasitic worms.

Considering that the conditions being treated are generally not severe and given the neurological risk identified, the EMA determined that the benefit-risk balance is now unfavorable.

In its